Method of treating ischemia reperfusion injury using adenosine receptor antagonists

Details for Australian Patent Application No. 2003236509 (hide)

Owner BIOGEN, INC.

Inventors Gross, Garrett J.; Jin, Xiaowei; Auchampach, John; Smits, Glenn J.

Agent Cullens

Pub. Number AU-A-2003236509

PCT Number PCT/US03/18695

PCT Pub. Number WO2003/105666

Priority 60/388,680 12.06.02 US

Filing date 12 June 2003

Wipo publication date 31 December 2003

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/388,680 12.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-A-2003236509

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003236510-ANTISENSE MODULATION OF PTPN12 EXPRESSION

2003236508-EPSTEIN-BARR VIRUS-SPECIFIC IMMUNIZATION